Discontinuing Prophylactic Transfusions Used to Prevent Stroke in Sickle Cell Disease
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Prophylactic transfusion prevents strokes in children with sickle cell anemia who have abnormalities on transcranial Doppler ultrasonographic examination. However, it is not known how long transfusion should be continued in these children. METHODS: We studied children with sickle cell disease who had a high risk of stroke on the basis of a transcranial Doppler screening examination and who had received transfusions for 30 months or longer, during which time the Doppler readings became normal. The children were randomly assigned to continued transfusion or no continued transfusion. Children with severe stenotic lesions on cerebral magnetic resonance angiography were excluded. The composite primary end point was stroke or reversion to a result on Doppler examination indicative of a high risk of stroke. RESULTS: The study was stopped after 79 children of a planned enrollment of 100 underwent randomization. Among the 41 children in the transfusion-halted group, high-risk Doppler results developed in 14 and stroke in 2 others within a mean (+/-SD) of 4.5+/-2.6 months (range, 2.1 to 10.1) of the last transfusion. Neither of these events of the composite end point occurred in the 38 children who continued to receive transfusions. The average of the last two transcranial Doppler results before transfusion was started was the only predictor of the composite end point (P=0.05). CONCLUSIONS: Discontinuation of transfusion for the prevention of stroke in children with sickle cell disease results in a high rate of reversion to abnormal blood-flow velocities on Doppler studies and stroke. (ClinicalTrials.gov number, NCT00006182.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the approximately 22% of children who did not achieve normalization of transcranial Doppler velocity in spite of optimal transfusion in the trial were also protected from stroke (162).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [162]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Rother, R. P., Bell, L., Hillmen, P., & Gladwin, M. T. (2005) · JAMA · doi:10.1001/jama.293.13.1653 · Cited by 1,557
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Steinberg, M. H., Barton, F., Castro, O., Pegelow, C. H., Ballas, S. K., Kutlar, A., Orringer, E., Bellevue, R., Olivieri, N., Eckman, J., et al. (2003) · JAMA · doi:10.1001/jama.289.13.1645 · Cited by 931
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., et al. (2001) · Stroke · doi:10.1161/01.str.32.1.280 · Cited by 905
The Use of Transcranial Ultrasonography to Predict Stroke in Sickle Cell Disease
Adams, R., McKie, V., Nichols, F., Carl, E., Zhang, D.-L., McKie, K., Figueroa, R., Litaker, M., Thompson, W., & Hess, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202273260905 · Cited by 658
Research works printed but not linked: 2
- Ohene-Frempong K, 1998, Blood, 91, 288
- Walters MC, 2000, Blood, 95, 1918
Cited by
Items 501–600 of 665
Ultrasound in Stroke Prevention: TCD and Sickle Cell Disease
Nichols, F. T., Adams, R. J., & Jones, A. M. (2011) · Wiley eBooks · doi:10.1002/9781444327373.ch7 · Cited by 1
Stem cells in the treatment of sickle cell disease
Gallicchio, V. S., & McGill, E. (2020) · Journal of Stem Cell Research & Therapeutics · doi:10.15406/jsrt.2020.06.00138 · Cited by 1
Hematologic Disorders and Stroke
Lisle, B., & Bushnell, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-69424-7.00042-9 · Cited by 1
Grand challenges in pediatric stroke
Ullman, N. L., & Licht, D. J. (2023) · Frontiers in Stroke · doi:10.3389/fstro.2023.1204718 · Cited by 1
Dhiman, Y., Khatiwada, B., Das, K., Raturi, M., & Gaur, D. S. (2024) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2024.01.006 · Cited by 1
Functional transcranial dopplerography is a diagnostic tool for cognitive impairment syndrome
Polyakova, A. V., Pushkin, M. S., Kutkova, A., & Voznyuk, I. A. (2024) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20241240217 · Cited by 1
Prevalence of red blood cell alloantibodies in pregnant women with sickle cell disease in Bamako
Fomba, M., Touré, B. A., Toly‐Ndour, C., Bagayoko, A., & Baby, M. (2024) · Transfusion Medicine · doi:10.1111/tme.13074 · Cited by 1
Creary, S. E., Chung, M. G., Villella, A. D., & Lo, W. D. (2024) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-024-01372-9 · Cited by 1
Wu, X., Stratford, J. K., Kesler, K. L., Ives, C. L., Hendershot, T. P., Kroner, B. L., Qin, Y., & Pan, H. H. (2025) · PLoS ONE · doi:10.1371/journal.pone.0309572 · Cited by 1
Padarti, A., Quinn, C. T., Kwiatkowski, J. L., McNaull, M., Kirkham, F. J., Plumb, P. A., Hynan, L. S., & Dowling, M. M. (2025) · PubMed · Cited by 1
Transcranial Doppler Ultrasound Applications in Neurology and Neurocritical Care: Literature Review
Rouanet, C., Marques, I. P., dos Santos, D. P. D. A., Rodrigues, B. C. B., & Fernandes, R. D. C. L. (2025) · Revista brasileira de neurologia · doi:10.46979/rbn.v61i2.67021 · Cited by 1
Chandrasekar, A. P., Koepsell, S. A., Williams, S. M., & Bobr, A. (2025) · Case Reports in Hematology · doi:10.1155/crh/9580128 · Cited by 1
Benefits of isovolemic hemodilution red cell exchange: Real or imagined?
Nourse, B., Reddy, M. S., Jones, J. M., & Tran, M. (2026) · Transfusion · doi:10.1111/trf.70166 · Cited by 1
Xavier, F. D. S., da Silva, M. O., Pereira, L. F. M., Seber, A., & Duarte, M. L. (2026) · Radiologia Brasileira · doi:10.1590/0100-3984.2025.0090 · Cited by 1
Nadim, M. K., Choi, A., Parisi, N., & Akgün, Y. (2026) · Journal of Clinical Apheresis · doi:10.1002/jca.70169 · Cited by 1
Transfusion Management in Patients with Hemoglobinopathies
Shaz, B. H. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374432-6.00045-2 · Cited by 1
Accidents vasculaires cérébraux de l'enfant (nouveau-né exclu)
Kossorotoff, M., Lebas, A., Chabrier, S., & Puget, S. (2013) · Cited by 1
MRI abnormalities in infants with sickle cell anemia—indication for preemptive therapy?
Ozsahin, H. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21704 · Cited by 1
Carpenter, J. L., & Hulbert, M. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-62328-3_6 · Cited by 1
Fasano, R. M., & Luban, N. L. C. (2008) · Clínicas pediátricas de Norteamérica · Cited by 1
Selection of a stroke risk model based on transcranial Doppler ultrasound velocity
Mukhopadhyay, S., Das, I., & Das, K. (2012) · Journal of Applied Statistics · doi:10.1080/02664763.2012.725463 · Cited by 1
Clinical utility of carotid and transcranial ultrasound in cerebrovascular diseases
Lange, M. C., Figueiredo, L., & Zétola, V. D. H. F. (2014) · Journal of Vascular Diagnostics and Interventions · doi:10.2147/jvd.s49650 · Cited by 1
Telfer, P. T. (2013) · Thalassemia Reports · doi:10.4081/thal.2013.s1.e29 · Cited by 1
van Mieghem, C. A. G., Ramcharitar, S., Barlis, P., Oosterhuis, W., Kik, C., de Feyter, P. J., & Serruys, P. W. J. C. (2008) · EuroIntervention · doi:10.4244/eijv3i5a112 · Cited by 1
Neurological Manifestations of Hematological Disease
Weksler, B. B. (2007) · Elsevier eBooks · doi:10.1016/b978-012088592-3/50061-x · Cited by 1
Neurological Complications and MRI
Kawadler, J. M., & Kirkham, F. J. (2016) · InTech eBooks · doi:10.5772/64143 · Cited by 1
Amlie‐Lefond, C., & Shaw, D. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53486-6.00060-0 · Cited by 1
Incomplete implementation of guideline‐based stroke prevention therapy in sickle cell disease
Schlenz, A. M., Hayes, J., Mueller, M., Phillips, S. M., Adams, R. J., & Kanter, J. (2018) · American Journal of Hematology · doi:10.1002/ajh.25163 · Cited by 1
Stroke in Children: Recognizing Opportunities for Improving Care
Jordan, L. C. (2019) · Stroke · doi:10.1161/strokeaha.118.023549 · Cited by 1
Carpentieri-Pipolo, G., Oliveira, M. D. L., Paschoal, F. M., & Bor‐Seng‐Shu, E. (2019) · Neuroscience & Medicine · doi:10.4236/nm.2019.102011 · Cited by 1
Transfusion in Sickle cell disease: best practice and understanding of its utility
Shi, P. A., & Yazdanbakhsh, K. (2020) · ISBT Science Series · doi:10.1111/voxs.12549 · Cited by 1
Sheriff, F. G., Sheriff, S., Rao, S. S., & Chung, D. Y. (2020) · Current clinical neurology · doi:10.1007/978-3-030-36548-6_25 · Cited by 1
Impact of sickle cell disease on executive functioning in an adult population
Wade, C. (2020) · Pepperdine Digital Commons (Pepperdine University) · Cited by 1
Stroke Treatment in the Setting of Systemic Disease
Arthur, K. C., Fracica, E. A., & Johansen, M. C. (2020) · Current Treatment Options in Neurology · doi:10.1007/s11940-020-00650-4 · Cited by 1
Fé, L. R. M. M., & da Costa, G. A. (2022) · Jornal de Ciências da Saúde do Hospital Universitário da Universidade Federal do Piauí · doi:10.26694/jcs_hu-ufpi.v2i3.11892 · Cited by 1
Treatment of “Other” Stroke Etiologies
Cucchiara, B. L., & Kasner, S. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-69424-7.00058-2 · Cited by 1
Kim, H. H. R., Kim, W. G., Lee, E. Y., & Phillips, G. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-56802-3_2 · Cited by 1
Babikian, V. L., & Tegeler, C. H. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7506-7525-3.50045-5 · Cited by 1
Falcone, G. J., & Amin, H. (2020) · Springer eBooks · doi:10.1007/978-3-030-52552-1_10 · Cited by 1
Cerebral Vasculopathy in Children With Sickle Cell Disease in an Amazonian Population
Tobelem, F. L. A., de Andrade, G. A. L. R., Paschoal, J. K. S. F., Cardoso, M. D. S. D. O., Trindade, S. M. S., Paschoal, E. H. A., Paschoal-Jr, F. M., & Bor‐Seng‐Shu, E. (2022) · Journal of Child Neurology · doi:10.1177/08830738221100088 · Cited by 1
Detection and Management of Cerebral Vasculopathy
Bernaudin, F., & Verlhac, S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105099 · Cited by 1
Serum Ferritin Levels of Steady State Sickle Cell Anaemia Children in Enugu Southeast Nigeria
Eneh, C. I., Nwankwo Chinweoke, A., & Ihuoma, J. C. (2023) · Journal of Advances in Medicine and Medical Research · doi:10.9734/jammr/2023/v35i125031 · Cited by 1
Molecular and environmental contributors to neurological complications in sickle cell disease
Karkoska, K. A., Gollamudi, J., & Hyacinth, H. I. (2023) · Experimental Biology and Medicine · doi:10.1177/15353702231187646 · Cited by 1
Reggiani, G., Boaro, M. P., & Colombatti, R. (2023) · La Presse Médicale · doi:10.1016/j.lpm.2023.104201 · Cited by 1
Iron absorption in adults with sickle cell anemia: a stable-isotope approach
Omena, J., Bezerra, F. F., Voll, V. M., Braz, B. F., Santelli, R. E., Donangelo, C. M., Jauregui, G. F., Ribeiro, A. S., Rodrigues, C. D. S. C., & Citelli, M. (2024) · European Journal of Nutrition · doi:10.1007/s00394-024-03417-8 · Cited by 1
Shaikh, A. A., Gangaplara, A., Kone, A. M., Almengo, K., Kabore, M. D., Ali, M. A., Xu, X., Saxena, A., Lopez-Ocasio, M. D., McCoy, J. P., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1411392 · Cited by 1
12 Pediatric Sickle Cell Disease and Stroke
Krejza, J., Świat, M., Tomaszewski, M., & Melhem, E. R. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7777-9_12 · Cited by 1
XXXVIII Congresso Nazionale AIEOP, Roma 9-11 giugno 2013 - Relazioni
Infermieristiche, R. S. P. M. E. (2013) · Pediatric Reports · doi:10.4081/2013.s1.rel · Cited by 1
MR-Based Mapping of Cerebral Hemodynamics in Children with Sickle Cell Disease
Kosinski, P. D. (2016) · TSpace (University of Toronto) · Cited by 1
Molecular and clinical factors affecting myocardial iron retention in transfusional haemosiderosis
Garbowski, M. (2017) · UCL Discovery (University College London) · Cited by 1
Pediatric Transfusion Medicine
Josephson, C. D., & Sloan, S. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00121-9 · Cited by 1
Aloimunização eritrocitária e HLA em doença falciforme
Santos, F. L. S. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2021.tde-11062021-081805 · Cited by 1
Déficits cognitifs chez les enfants et adolescents souffrant de drépanocytose
Ruffieux, N. (2011) · Archive ouverte UNIGE (University of Geneva) · doi:10.13097/archive-ouverte/unige:16874 · Cited by 1
Moderate dose of hydroxyurea in children with sickle cell disease and stroke. Preliminary results.
Machín-García, S., Menéndez-Veitía, A., Scherle-Matamoros, C., Svarch, E., González-Otero, A., Arencibia-Núñez, A., Gutiérrez-Díaz, A., & Lam-Díaz, R. M. (2014) · Revista cubana de hematología, inmunología y hemoterapia
Kirkham, F. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00102-9
Colino, C. G. (2013) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Mallouh, A. A. (2012) · Springer eBooks · doi:10.1007/978-3-642-02202-9_324
The Therapeutic Use of Red Blood Cells
Meny, G. M., & Liao, L. F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.06205-5
Regular Transfusions, Iron, and Teenage Pregnancy
Mijović, A. (2011) · Springer eBooks · doi:10.1007/978-1-4471-2182-4_11
CHILDREN WITH SICKLE CELL DISEASE RISK STROKE IF TRANSFUSIONS CEASE
Gillis, D. (2006) · Neurology Today · doi:10.1097/00132985-200602070-00006
Sickle-Cell Disease and Stroke: Evidence-Based Neuroimaging
Krejza, J., Arkuszewski, M., Świat, M., Tomaszewski, M., & Melhem, E. R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-3320-0_12
Accidenti vascolari cerebrali del bambino (escluso il neonato)
Kossorotoff, M., Lebas, A., Chabrier, S., & Puget, S. (2014) · EMC - Urgenze · doi:10.1016/s1286-9341(14)66730-2
Acute Ischemic Stroke: Evidence-Based Neuroimaging
Ford, A. L., Lee, J., Lin, W., & Vo, K. D. (2013) · Springer eBooks · doi:10.1007/978-1-4614-3320-0_11
Steinberg, M. H. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.026
Ischemic stroke in a child with complex cyanotic congenital heart disease
Rugina, A. L., Ștreangă, V., Nistor, N., Buhuşi, G., Filipescu, R., & Ciomagă, I.-M. (2014) · Romanian Journal of Pediatrics · doi:10.37897/rjp.2014.3.13
Meschia, J. F., Moore, W. S., Pearson, T. A., Hart, R. G., Hinchey, J. A., Howard, V. J., Jauch, E. C., Chaturvedi, S., Creager, M. A., Culebras, A., et al. (2010)
Molecular Pathology of Hemoglobin and Erythrocyte Membrane Disorders
Arcasoy, M. O., & Gallagher, P. G. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-5698-9_37
NEW APPROACHES TO THE TREATMENT OF HEMOGLOBINOPATHIES AND THALASSEMIA
Steinberg, M. H., Forget, B. G., Higgs, D. R., & Weatherall, D. J. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.039
Sleep Problems in Children with Sickle Cell Disease
Khatwa, U., Bazzy‐Asaad, A., & Kothare, S. V. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-725-9_24
Discontinuing Prophylactic Transfusions Used to Prevent Stroke in Sickle Cell Disease
STOCKMAN, J. A. (2007) · Yearbook of Pediatrics · doi:10.1016/s0084-3954(08)70029-0
Preventing Stroke in Sickle-Cell Disease
Bauchner, H. (2006) · Journal watch · doi:10.1056/pa200602100000002
Torbey, M., & Selim, M. H. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139344296.017
Meirelles, A. F. G. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.60.2016.tde-02052016-105840
Hemoglobinopaties greus més freqüents al nostre entorn
de Heredia, C. D. (2008) · Pediatria catalana: butlletí de la Societat Catalana de Pediatria
Stroke Prevention Trials in Sickle Cell Anemia
Millichap, J. G. (2006) · Pediatric Neurology Briefs · doi:10.15844/pedneurbriefs-20-6-10
Treatment of “Other” Stroke Etiologies
Kasner, S. E., & Cucchiara, B. L. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5478-8.10054-5
Amlie‐Lefond, C. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139344296.019
Neurocritical Care in Children
Pineda, J. A., & Wainwright, M. S. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5316-3.00177-5
Ultrasound and other noninvasive techniques used in monitoring cerebrovascular disease
Seidel, G. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9780511659096.006
Hemostatic Aspects of Sickle Cell Disease
Ataga, K. I., & Lottenberg, R. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2296-9.00046-4
Amin, H., & Schindler, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-39605-7_10
Sickle Cell Disease: Prevention of Complications
Novelli, E. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-30352-9_7
Childhood Cerebrovascular Disease
Vossough, A., & Zimmermann, R. A. (2016) · Springer eBooks · doi:10.1007/978-3-662-46258-4_13-1
Thalassemia and sickle cell disease
Roberts, I. A. G., & de la Fuente, J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-443-10147-2.50021-7
MRI Based Quantification Of Cerebrovascular Health In Pediatric Subjects With Sickle Cell Disease
Kim, J. (2015) · TSpace (University of Toronto)
Soleros — natural absorbers of mineral salts
Константинова, Е. А., Велиева, Н. Т., & Нурмухамбетова, С. А. (2017) · Молодой ученый
Jasim, T. A. (2015) · kufa journal for nursing sciences · doi:10.36321/kjns.vi20152.2604
Iron Chelator in Patients with Sickle Cell Anemia, Comparative Study
Jasim, T. A. (2015) · kufa journal for nursing sciences · doi:10.36321/kjns.vi20143.2769
Perioperative Management of Paediatric Patients with Sickle Cell Disease
Sullivan, K., Dayan, J., Reichenbach, M. R., Irwin, M. G., Pitkin, A., Gauger, C. A., Goodwin, S. R., & Kissoon, N. “. (2017) · West Indian Medical Journal · doi:10.7727/wimj.2017.135
Genetic and biological markers of severity in sickle cell disease
Drašar, E. (2014) · Research Portal (King's College London)
Black, L. V., Ramesar, J., & Boston, C. H. (2018) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000001172
Nicanor, J. S. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2018.tde-17042018-160546
Oliveira, W. R. (2013) · Institutional Repository of the Federal University of Sergipe (Universidade Federal de Sergipe)
Comparison of Two Methods of Transfusion Therapy for Stroke Prevention in Sickle Cell
Keates‐Baleeiro, J., Mixon, A., Bhakta, M. G., & McManus, M. P. (2018) · Journal of Blood Disorders & Transfusion · doi:10.4172/2155-9864.1000405
Hematopoietic Cell Transplantation for Sickle Cell Disease
Walters, M. C. (2015) · Wiley eBooks · doi:10.1002/9781118416426.ch72
Gunjal, S. (2019) · ResearchWorks at the University of Washington (University of Washington)
Prado, B. D. P. A. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2020.tde-12112019-100212
Treatment of “Other” Stroke Etiologies
Kasner, S. E., & Cucchiara, B. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-29544-4.00056-6
Metadata
- Authors
- The Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators
- Affiliations
- Augusta University (US)
- Corresponding author
- The Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-12-29
- Volume
- 353
- Issue
- 26
- Pages
- 2769-2778
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1498156640
- Cited by
- 635
- References
- 27
- Citations by year
- 2026: 23 · 2025: 12 · 2024: 31 · 2023: 22 · 2022: 29 · 2021: 27 · 2020: 34 · 2019: 25 · 2018: 35 · 2017: 37 · 2016: 43 · 2015: 25 · 2014: 32 · 2013: 32 · 2012: 45
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (U01HL052193, U01HL052016)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- sickle cell disease, stroke prevention, prophylactic transfusion, transcranial Doppler screening, cerebral blood flow velocity, children
- MeSH terms
- Adolescent, Adult, Anemia, Sickle Cell, Blood Flow Velocity, Blood Transfusion, Brain, Child, Female, Humans, Magnetic Resonance Imaging, Male, Risk, Chelation Therapy, Ultrasonography, Doppler, Transcranial, Stroke, Middle Cerebral Artery, Withholding Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.